Home / Health / Dr Reddy's to launch Molflu at Rs 35 per capsule for Covid treatment

Dr Reddy's to launch Molflu at Rs 35 per capsule for Covid treatment

The overall cost for a patient treated with a 5-day course of 40 capsules of the generic drug, to be sold under brand name 'Molflu', will come up to Rs 1,400

Premium

Representative Image

2 min read Last Updated : Jan 04 2022 | 5:22 PM IST

Indian drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir, and price it at Rs 35 ($0.4693) per capsule, a company spokesperson said on Tuesday.

The overall cost for a patient treated with a 5-day course of 40 capsules of the generic drug, to be sold under brand name 'Molflu', will come up to Rs 1,400 ($18.77). In comparison, the treatment with Merck's pill in the United States costs $700.

"Molflu is expected to be available from early next week in pharmacies throughout (India) with particular focus on states with high caseload of

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Topics : Coronavirus Omicron Coronavirus Vaccine Dr Reddy's

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in